Evidence map›Paper›PMID 37119330›Full record

ArticleActa neuropathologica2023

AMFR dysfunction causes autosomal recessive spastic paraplegia in human that is amenable to statin treatment in a preclinical model.

Ruizhi Deng, Eva Medico-Salsench, Anita Nikoncuk, Reshmi Ramakrishnan, Kristina Lanko, Nikolas A Kühn, Herma C van der Linde, Sarah Lor-Zade, Fatimah Albuainain, Yuwei Shi and 42 more

Open access · hybridAbstract read
In one paragraph

Article in Acta neuropathologica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. A Report of a Child with SEC31A-Related Neurodevelopmental Disorder.International journal of molecular sciences · 2025
    Article
  5. Review
  6. Article
  7. A Novel Loss of Function Variant inMolecular syndromology · 2025
    Article
  8. Article
  9. Experimental Cell Models for Investigating Neurodegenerative Diseases.International journal of molecular sciences · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

52 authors at 16 institutions in 9 countries.

Ruizhi Deng *Department of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.ORCID 0000-0002-5406-2560
Eva Medico-SalsenchDepartment of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.ORCID 0000-0002-0263-0458
Anita NikoncukDepartment of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Reshmi RamakrishnanBioscience Program, Biological and Environmental Science and Engineering Division, Computational Bioscience Research Center, King Abdullah University of Science and Technology (KAUST), Thuwal, 23955-6900, Saudi Arabia.
Kristina LankoDepartment of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Nikolas A KühnDepartment of Cell Biology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Herma C van der LindeDepartment of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Sarah Lor-ZadeDepartment of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Fatimah AlbuainainDepartment of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Yuwei ShiDepartment of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Soheil YousefiDepartment of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Ivan CapoDepartment for Histology and Embryology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia.
Evita Medici van den HerikDepartment of Neurology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.ORCID 0000-0002-7744-1352
Marjon van SlegtenhorstDepartment of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Rick van MinkelenDepartment of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Geert GeevenDepartment of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.ORCID 0000-0002-5603-0095
Monique T MulderDepartment of Internal Medicine, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
George J G RuijterDepartment of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Dieter LütjohannInstitute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn, Germany.
Edwin H JacobsDepartment of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Henry HouldenDepartment of Neuromuscular Disorders, UCL Queen Square Institute of Neurology, London, UK.
Alistair T PagnamentaNIHR Biomedical Research Centre, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
Kay MetcalfeManchester Centre for Genomic Medicine, St Mary's Hospital, Health Innovation Manchester, Manchester University Foundation NHS Trust, Manchester, UK.
Adam JacksonManchester Centre for Genomic Medicine, St Mary's Hospital, Health Innovation Manchester, Manchester University Foundation NHS Trust, Manchester, UK.
Siddharth BankaManchester Centre for Genomic Medicine, St Mary's Hospital, Health Innovation Manchester, Manchester University Foundation NHS Trust, Manchester, UK.
Lenika De SimoneDivision of Neurology, Division of Genetics, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, USA.
Abigail SchwaedeDivision of Neurology, Division of Genetics, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, USA.
Nancy KuntzDivision of Neurology, Division of Genetics, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, USA.
Timothy Blake PalculictGeneDx, Gaithersburg, MD, 20877, USA.
Safdar AbbasDepartment of Biological Science, Dartmouth College, Hanover, NH, USA.
Muhammad UmairMedical Genomics Research Department, King Abdullah International Medical Research Center (KAIMRC), King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
Mohammed AlMuhaizeaNeuroscience Centre, King Faisal Specialist Hospital and Research Centre (KFSHRC), MBC: 76, Riyadh, 11211, Saudi Arabia.
Dilek ColakMolecular Oncology Department, King Faisal Specialist Hospital and Research Centre (KFSHRC), MBC: 03, Riyadh, 11211, Saudi Arabia.ORCID 0000-0001-6485-8768
Hanan AlQudairyTranslational Genomics Department, Center for Genomics Medicine, King Faisal Specialist Hospital and Research Centre, MBC: 26, PO Box: 3354, Riyadh, 11211, Saudi Arabia.
Maysoon AlsagobTranslational Genomics Department, Center for Genomics Medicine, King Faisal Specialist Hospital and Research Centre, MBC: 26, PO Box: 3354, Riyadh, 11211, Saudi Arabia.
Catarina PereiraCENTOGENE, GmbH, 18055, Rostock, Germany.
Roberta TrunzoCENTOGENE, GmbH, 18055, Rostock, Germany.
Vasiliki KarageorgouCENTOGENE, GmbH, 18055, Rostock, Germany.
Aida M Bertoli-AvellaCENTOGENE, GmbH, 18055, Rostock, Germany.
Peter BauerCENTOGENE, GmbH, 18055, Rostock, Germany.
Arjan BoumanDepartment of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.ORCID 0000-0002-9560-6333
Lies H HoefslootDepartment of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Tjakko J van HamDepartment of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Mahmoud IssaClinical Genetics Department, Human Genetics and Genome Research Institute, National Research Centre, Cairo, Egypt.ORCID 0000-0002-3899-2821
Maha S ZakiClinical Genetics Department, Human Genetics and Genome Research Institute, National Research Centre, Cairo, Egypt.
Joseph G GleesonDepartments of Neurosciences and Pediatrics, Howard Hughes Medical Institute, University of California, Rady Children's Institute for Genomic Medicine, San Diego, USA.
Rob WillemsenDepartment of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Namik KayaTranslational Genomics Department, Center for Genomics Medicine, King Faisal Specialist Hospital and Research Centre, MBC: 26, PO Box: 3354, Riyadh, 11211, Saudi Arabia.
Stefan T AroldBioscience Program, Biological and Environmental Science and Engineering Division, Computational Bioscience Research Center, King Abdullah University of Science and Technology (KAUST), Thuwal, 23955-6900, Saudi Arabia.
Reza MaroofianDepartment of Neuromuscular Disorders, UCL Queen Square Institute of Neurology, London, UK.
Leslie E SandersonDepartment of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.ORCID 0000-0002-8026-406X
Tahsin Stefan BarakatDepartment of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands. t.barakat@erasmusmc.nl.ORCID 0000-0003-1231-1562
Erasmus MC · NLCentogene (Germany) · DEKing Faisal Specialist Hospital & Research Centre · SALurie Children's Hospital · USUniversity of Manchester · GBNational Hospital for Neurology and Neurosurgery · GBNational Research Centre · EGCentre for Human Genetics · GBCentre National de la Recherche Scientifique · FRChildren’s Institute · USDartmouth College · USKing Abdulaziz City for Science and Technology · SAKing Abdullah University of Science and Technology · SAKing Saud bin Abdulaziz University for Health Sciences · SAUniversity Hospital Bonn · DEUniversity of Novi Sad · RS

Funding

Wellcome Trust
6 · The paper itself

Abstract

Hereditary spastic paraplegias (HSP) are rare, inherited neurodegenerative or neurodevelopmental disorders that mainly present with lower limb spasticity and muscle weakness due to motor neuron dysfunction. Whole genome sequencing identified bi-allelic truncating variants in AMFR, encoding a RING-H2 finger E3 ubiquitin ligase anchored at the membrane of the endoplasmic reticulum (ER), in two previously genetically unexplained HSP-affected siblings. Subsequently, international collaboration recognized additional HSP-affected individuals with similar bi-allelic truncating AMFR variants, resulting in a cohort of 20 individuals from 8 unrelated, consanguineous families. Variants segregated with a phenotype of mainly pure but also complex HSP consisting of global developmental delay, mild intellectual disability, motor dysfunction, and progressive spasticity. Patient-derived fibroblasts, neural stem cells (NSCs), and in vivo zebrafish modeling were used to investigate pathomechanisms, including initial preclinical therapy assessment. The absence of AMFR disturbs lipid homeostasis, causing lipid droplet accumulation in NSCs and patient-derived fibroblasts which is rescued upon AMFR re-expression. Electron microscopy indicates ER morphology alterations in the absence of AMFR. Similar findings are seen in amfra-/- zebrafish larvae, in addition to altered touch-evoked escape response and defects in motor neuron branching, phenocopying the HSP observed in patients. Interestingly, administration of FDA-approved statins improves touch-evoked escape response and motor neuron branching defects in amfra-/- zebrafish larvae, suggesting potential therapeutic implications. Our genetic and functional studies identify bi-allelic truncating variants in AMFR as a cause of a novel autosomal recessive HSP by altering lipid metabolism, which may potentially be therapeutically modulated using precision medicine with statins.

Indexed as

Hydroxymethylglutaryl-CoA Reductase InhibitorsSpastic Paraplegia, HereditaryAnimalsHumansMotor NeuronsMutationReceptors, Autocrine Motility FactorZebrafishAMFR protein, humanHydroxymethylglutaryl-CoA Reductase InhibitorsReceptors, Autocrine Motility FactorAMFRCholesterol metabolismGeneticsHereditary spastic paraplegiaNeurologyPrecision medicineStatinWhole genome sequencingZebrafish disease modeling

Identifiers

PMID37119330
PMCPMC10328903
OpenAlexW4367394962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.